131 related articles for article (PubMed ID: 6994153)
1. Correction of increased prostacyclin synthesis in Bartter's syndrome by indomethacin treatment.
Gullner HG; Smith JB; Cerletti C; Gill JR; Bartter FC
Prostaglandins Med; 1980 Feb; 4(2):65-72. PubMed ID: 6994153
[TBL] [Abstract][Full Text] [Related]
2. Prostacyclin overproduction in Bartter's syndrome.
Güllner HG; Cerletti C; Bartter FC; Smith JB; Gill JR
Lancet; 1979 Oct; 2(8146):767-9. PubMed ID: 90861
[TBL] [Abstract][Full Text] [Related]
3. Correction of increased prostacyclin production in Bartter's syndrome by indomethacin.
Güllner HG; Cerletti C; Bartter FC; Gill JR; Smith JB
Trans Assoc Am Physicians; 1980; 93():130-40. PubMed ID: 7018063
[No Abstract] [Full Text] [Related]
4. Urinary prostaglandins in Bartter's and pseudo-Bartter's syndrome.
Hornych A; Krief C; Aumont J
Uremia Invest; 1985-1986; 9(2):203-10. PubMed ID: 3870249
[TBL] [Abstract][Full Text] [Related]
5. The principal metabolites of arachidonic acid are overproduced in Bartter's syndrome.
Güllner HG; Smith JB; Bartter FC
Adv Prostaglandin Thromboxane Res; 1980; 7():1185-7. PubMed ID: 6892749
[No Abstract] [Full Text] [Related]
6. Bartter's syndrome: contrasting patterns of prostaglandin excretion in children and adults.
Dray F
Clin Sci Mol Med; 1978 Jan; 54(1):115-8. PubMed ID: 620489
[TBL] [Abstract][Full Text] [Related]
7. The role of prostaglandins in Bartter's syndrome.
Winterborn MH; Hewitt GJ; Mitchell MD
Int J Pediatr Nephrol; 1984 Mar; 5(1):31-8. PubMed ID: 6370882
[TBL] [Abstract][Full Text] [Related]
8. Urinary excretion rate of 6-keto-prostaglandin F1 alpha as an index of circulating prostacyclin.
Seyberth HW; Müller H; Soeding K; Wille L; Hackenthal E
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():533-8. PubMed ID: 6221575
[No Abstract] [Full Text] [Related]
9. Bartter's syndrome: urinary prostaglandin E-like material and kallikrein; indomethacin effects.
Halushka PV; Wohltmann H; Privitera PJ; Hurwitz G; Margolius HS
Ann Intern Med; 1977 Sep; 87(3):281-6. PubMed ID: 900671
[TBL] [Abstract][Full Text] [Related]
10. Systemic prostaglandin I2 synthesis is normal in patients with Bartter's syndrome.
Watson ML; Gill JR; Branch RA; Oates JA; Brash AR
Lancet; 1983 Aug; 2(8346):368-70. PubMed ID: 6135873
[TBL] [Abstract][Full Text] [Related]
11. Urinary excretion of arterial blood prostaglandins and thromboxanes in man.
Zipser RD; Martin K
Am J Physiol; 1982 Mar; 242(3):E171-7. PubMed ID: 6950668
[TBL] [Abstract][Full Text] [Related]
12. Raised urinary prostaglandins in patient without Bartter's syndrome.
Nivet H; Grenier B; Rolland JC; Lebranchu Y; Dray F
Lancet; 1978 Feb; 1(8059):333-4. PubMed ID: 75374
[No Abstract] [Full Text] [Related]
13. Bartter's syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis.
Gill JR; Frölich JC; Bowden RE; Taylor AA; Keiser HR; Seyberth HW; Oates JA; Bartter FC
Am J Med; 1976 Jul; 61(1):43-51. PubMed ID: 820194
[TBL] [Abstract][Full Text] [Related]
14. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects.
Chiabrando C; Rivoltella L; Martelli L; Valzacchi S; Fanelli R
Biochim Biophys Acta; 1992 Feb; 1133(3):247-54. PubMed ID: 1737057
[TBL] [Abstract][Full Text] [Related]
15. [Plasma and urinary prostaglandins in Bartter's and pseudo-Bartter's syndrome (author's transl)].
Hornych A
Nephrologie; 1980; 1(3):113-6. PubMed ID: 6945487
[TBL] [Abstract][Full Text] [Related]
16. Presence of thromboxane B2 and 6-keto-prostaglandin F1 alpha in the urine of fetal sheep.
Walker DW; Mitchell MD
Prostaglandins Med; 1979 Oct; 3(4):249-50. PubMed ID: 583578
[No Abstract] [Full Text] [Related]
17. Bartter's syndrome with normal urinary excretion of prostaglandin E: therapeutic effects of propranolol, spironolactone, indomethacin and potassium chloride.
Sato M; Abe K; Yasujima M; Otsuka Y; Chiba S; Haruyama T; Yoshinaga K; Saito T; Kabuki J
Tohoku J Exp Med; 1980 Jun; 131(2):151-9. PubMed ID: 7404582
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin synthetase inhibitors in Bartter's syndrome. Effect on immunoreactive prostaglandin E excretion.
Bowden RE; Gill JR; Radfar N; Taylor AA; Keiser HR
JAMA; 1978 Jan; 239(2):117-21. PubMed ID: 412983
[TBL] [Abstract][Full Text] [Related]
19. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus.
Patrono C; Ciabattoni G; Remuzzi G; Gotti E; Bombardieri S; Di Munno O; Tartarelli G; Cinotti GA; Simonetti BM; Pierucci A
J Clin Invest; 1985 Sep; 76(3):1011-8. PubMed ID: 3900132
[TBL] [Abstract][Full Text] [Related]
20. On the pathogenetic role of prostaglandins in Bartter's syndrome.
Nielsen I; Hesse B; Christensen P
Acta Med Scand Suppl; 1979; 625():135-40. PubMed ID: 285569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
